Long-Acting Nanoformulation for the Delivery of Fusion Inhibitor Peptide & Small Molecule
Time: 9:30 am
day: Day Two
Details:
- Considerations of physicochemical properties of the drugs and peptide for designing a long-acting combination drug delivery platform
- Unveiling how the site of injection/administration drives the pharmacokinetics of longacting formulations
- Showcasing how the drug delivery strategy is predetermined based on the immune cell target
